These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17403991)

  • 1. Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine.
    Vytopil M; Mani R; Adlakha A; Zhu JJ
    Am J Psychiatry; 2007 Apr; 164(4):684. PubMed ID: 17403991
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment-emergent hypomania or mania with modafinil.
    Plante DT
    Am J Psychiatry; 2008 Jan; 165(1):134-5; author reply 135. PubMed ID: 18178756
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report.
    Clemons WE; Makela E; Young J
    Sleep Med; 2004 Sep; 5(5):509-11. PubMed ID: 15341899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra short manic-like episodes after antidepressant augmentation with modafinil.
    Fountoulakis KN; Siamouli M; Panagiotidis P; Magiria S; Kantartzis S; Iacovides A; Kaprinis GS
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):891-2. PubMed ID: 18068287
    [No Abstract]   [Full Text] [Related]  

  • 6. Coming into focus. Pharmacologic treatment for ADHD.
    McDonnell MA; Moffett C
    Adv NPs PAs; 2010 Dec; 1(4):16-22; quiz 23. PubMed ID: 21319448
    [No Abstract]   [Full Text] [Related]  

  • 7. Modafinil-induced reversible hyperkinetic nondystonic movement disorder in a patient with major depressive disorder.
    Luborzewski A; Regen F; Schindler F; Anghelescu I
    J Neuropsychiatry Clin Neurosci; 2006; 18(2):248-9. PubMed ID: 16720809
    [No Abstract]   [Full Text] [Related]  

  • 8. Modafinil augmentation of antidepressant treatment in depression.
    Menza MA; Kaufman KR; Castellanos A
    J Clin Psychiatry; 2000 May; 61(5):378-81. PubMed ID: 10847314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil in the treatment of depression with severe comorbid medical illness.
    Schwartz TL; Leso L; Beale M; Ahmed R; Naprawa S
    Psychosomatics; 2002; 43(4):336-7. PubMed ID: 12189262
    [No Abstract]   [Full Text] [Related]  

  • 10. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy.
    Markovitz PJ; Wagner S
    J Clin Psychopharmacol; 2003 Apr; 23(2):207-9. PubMed ID: 12640225
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulants for depression: On the up and up?
    Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G
    Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychostimulants, poststroke depression, and side effects.
    Masand PS
    J Clin Psychiatry; 1993 Sep; 54(9):356. PubMed ID: 8104931
    [No Abstract]   [Full Text] [Related]  

  • 14. Resting metabolic rate is reduced in patients treated with antidepressants.
    Fernstrom MH; Epstein LH; Spiker DG; Kupfer DJ
    Biol Psychiatry; 1985 Jun; 20(6):692-5. PubMed ID: 3995117
    [No Abstract]   [Full Text] [Related]  

  • 15. Serious adverse events and the modafinil augmentation study.
    Block J
    CNS Spectr; 2006 May; 11(5):340; author reply 340-2. PubMed ID: 16791971
    [No Abstract]   [Full Text] [Related]  

  • 16. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosis associated with modafinil and shift work.
    Mariani JJ; Hart CL
    Am J Psychiatry; 2005 Oct; 162(10):1983. PubMed ID: 16199854
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual and coenesthetic hallucinations associated with modafinil.
    Oulis P; Kouzoupis AV; Kontoangelos K; Pachou E; Masdrakis VG; Soldatos CR
    J Clin Psychopharmacol; 2008 Apr; 28(2):251-2. PubMed ID: 18344746
    [No Abstract]   [Full Text] [Related]  

  • 20. Comments on "Thrombocytopenia and delirium associated with tranylcypromine overdose".
    Munjack DJ; Adler M
    J Clin Psychopharmacol; 1996 Jun; 16(3):264-5. PubMed ID: 8784669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.